Microneedle-Based Continuous Levodopa Monitoring in Patients with Parkinson’s Disease
ACS Sensors · 28.08.2026 · 11 (8) · 7517-7530
DOI: 10.1021/acssensors.6c02083 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, online erschienen am 28.07.2026. Verfasst von Maria Reynoso und 16 weiteren Autor:innen. Beteiligte Einrichtung: Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, California92093, United States. Hauptthemen laut MEDLINE: Levodopa, Parkinson Disease, Biosensing Techniques, Antiparkinson Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, National Research Council of Thailand, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Optimal levodopa (L-Dopa) dosing for the personal management of Parkinson’s disease represents a major clinical challenge due to L-Dopa’s narrow therapeutic window and inter- and intra-patient absorption variability. Current methods for measuring L-Dopa, relying on repeated blood draws for centralized laboratory measurements, fall short of capturing dynamic L-Dopa fluctuations that are relevant for timely interventions. Here, we present a minimally invasive microneedle (MN)-based wearable biosensor for continuous monitoring of L-Dopa (CDM) in human subjects. The MN biosensor platform relies on a tyrosinase-functionalized working electrode for detecting L-Dopa in interstitial fluid (ISF) through enzymatic electrochemical detection. The device was evaluated in healthy volunteers and participants with Parkinson’s disease in clinical settings, illustrating its ability to provide actionable temporal insights. Critical validation of the MN biosensor was carried out by comparing the ISF L-Dopa signals with plasma L-Dopa concentrations measured by high-performance liquid chromatography (HPLC). Using subject-specific calibration and lag-time correction, the ISF-derived drug profiles showed a close correlation with plasma L-Dopa pharmacokinetics, with a mean absolute relative difference (MARD) of 9.64%. An inverse correlation between the L-Dopa pharmacokinetics and the corresponding motor performance was observed. Such pioneering demonstration of the clinical feasibility of MN-based CDM in humans highlights its considerable potential for supporting the management of Parkinson’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, California92093, United States.
- Department of Neurosciences, University of California San Diego, La Jolla, California92093, United States.
- Shu Chien - Gene Lay Department of Bioengineering, University of California San Diego, La Jolla, California92093, United States.
ORCID-Profile: Chochanon Moonla, Joseph Wang
Förderung
- NCATS NIH HHS
- National Research Council of Thailand
- National Center for Advancing Translational Sciences
Zitieren
APA
Reynoso, M., Moonla, C., Longardner, K., Chaiya, N., Surace, S., Chang, A. Y., Saha, T., Mahmood, U., Khan, M., Skipworth, M., McGregor, I., Damme, A. V., Vazquez, L. F., Shah, E., Luan, H., Litvan, I., & Wang, J. (2026). Microneedle-Based Continuous Levodopa Monitoring in Patients with Parkinson’s Disease. ACS Sensors, 11(8), 7517-7530. https://doi.org/10.1021/acssensors.6c02083
Vancouver
Reynoso M, Moonla C, Longardner K, Chaiya N, Surace S, Chang AY, et al. Microneedle-Based Continuous Levodopa Monitoring in Patients with Parkinson’s Disease. ACS Sensors. 2026;11(8):7517-7530. doi:10.1021/acssensors.6c02083
BibTeX
@article{Reynoso2026,
author = {Reynoso, Maria and Moonla, Chochanon and Longardner, Katherine and Chaiya, Nuenghathai and Surace, Stacey and Chang, An-Yi and Saha, Tamoghna and Mahmood, Umair and Khan, Muhammad and Skipworth, Michael and McGregor, Ian and Damme, Ava Van and Vazquez, Lidia F and Shah, Eshita and Luan, Hao and Litvan, Irene and Wang, Joseph},
title = {Microneedle-Based Continuous Levodopa Monitoring in Patients with Parkinson’s Disease},
journal = {ACS Sensors},
year = {2026},
volume = {11},
number = {8},
pages = {7517--7530},
doi = {10.1021/acssensors.6c02083}
}
EUVIMED